https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-positive-results-from-study-to-evaluate-efficacy-of-elamipretide-in-barth-patients-compared-to-natural-history-control-301006308.html
Stealth BioTherapeutics Announces Positive Results From Study to Evaluate Efficacy of Elamipretide...
/PRNewswire/ -- Stealth BioTherapeutics (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
stealth biotherapeuticspositive results
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-fda-acceptance-of-new-drug-application-for-elamipretide-for-the-treatment-of-barth-syndrome-302109608.html
STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE...
/PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...
new drug applicationstealth biotherapeutics
https://ctl.cornell.edu/about/startups/stealth-biotherapeutics-inc/
Stealth BioTherapeutics, Inc. - Center For Technology Licensing
Oct 6, 2022 - Stealth BioTherapeutics, Inc., is a clinical stage, biopharmaceutical company developing novel mitochondrial targeted therapies for diseases with clear unmet...
center for technologystealth biotherapeuticsinclicensing
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-presents-positive-sbt-272-preclinical-data-at-2021-annual-northeast-amyotrophic-lateral-sclerosis-neals-meeting-301395580.html
Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at 2021 Annual Northeast...
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and...
stealth biotherapeutics